Who makes Oxaluria evolution.?

Oxaluria evolution. is developed by Hospices Civils de Lyon.

What development phase is Oxaluria evolution. in?

Oxaluria evolution. is in Phase 2.

Last reviewed 2026-04-19 · How we verify

Oxaluria evolution.

Hospices Civils de Lyon · Phase 2 active Small molecule

At a glance

Generic name	Oxaluria evolution.
Sponsor	Hospices Civils de Lyon
Modality	Small molecule
Phase	Phase 2

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Retrospective and Prospective Follow-up of Patients With Primary Hyperoxaluria Type 1 Treated With Lumasiran in France.

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Oxaluria evolution. CI brief — competitive landscape report
Oxaluria evolution. updates RSS · CI watch RSS
Hospices Civils de Lyon portfolio CI